Influence of Dosing Schedule on Organ Exposure to Cyclosporin in Pediatric Hematopoietic Stem Cell Transplantation: Analysis with a PBPK Model View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2010-09-02

AUTHORS

Cécile Gérard, Nathalie Bleyzac, Pascal Girard, Gilles Freyer, Yves Bertrand, Michel Tod

ABSTRACT

ABSTRACTPurposeCyclosporin is administered by intermittent infusions (II) or continuous infusions (CI) to prevent acute graft-versus-host disease (aGVHD). Because cyclosporin disposition is nonlinear, organ exposure may be higher after II than after CI, but saturation of receptors must be accounted for. The aim of the study was to compare both types of administration using a mechanistic model.MethodsA physiologically based pharmacokinetic model was developed to estimate cyclosporin exposure and receptor occupancies (RO) in aGVHD target organs and kidneys and to compare these estimations in pediatric patients that received cyclosporin either by II or CI. The relevant biological parameters were based on a clinical study in 2 groups of pediatric patients that received cyclosporin either by II (n = 31) or CI (n = 30).ResultsSimulations showed that the exposure to cyclosporin in the interstitial fluid of aGVHD target organs was greater at day 1 after II than after CI. In kidneys, the opposite order was observed. AUCRO in all organs was greater after CI than after II. The therapeutic index (the ratio of AUCRO in blood to AUCRO in kidneys) was greater with CI than with II.ConclusionsCI may be slightly more favorable than II for aGVHD prevention. More... »

PAGES

2602-2613

References to SciGraph publications

  • 2003-10-01. Relationship between CsA trough blood concentration and severity of acute graft-versus-host disease after paediatric stem cell transplantation from matched-sibling or unrelated donors in BONE MARROW TRANSPLANTATION
  • 1999-12-01. Physiologically Based Pharmacokinetics of Cyclosporine A: Reevaluation of Dose–Nonlinear Kinetics in Rats in JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
  • 2001-05-01. Haematopoietic cell transplantation as immunotherapy in NATURE
  • 1997-04-01. A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow Transplantation (EBMT) in BONE MARROW TRANSPLANTATION
  • 2006-09. Prediction of the Clearance of Eleven Drugs and Associated Variability in Neonates, Infants and Children in CLINICAL PHARMACOKINETICS
  • 1999-09-01. Low-dose cyclosporine of short duration increases the risk of mild and moderate GVHD and reduces the risk of relapse in HLA-identical sibling marrow transplant recipients with leukaemia in BONE MARROW TRANSPLANTATION
  • 2006-09-18. Cyclosporine short infusion and C2 monitoring in haematopoietic stem cell transplant recipients in BONE MARROW TRANSPLANTATION
  • 2007-05. Exposure-Effect Population Model of Inolimomab, a Monoclonal Antibody Administered in First-Line Treatment for Acute Graft-Versus-Host Disease in CLINICAL PHARMACOKINETICS
  • 2003-10-16. Clinical and pharmacological risk factors for acute graft-versus-host disease after paediatric bone marrow transplantation from matched-sibling or unrelated donors in BONE MARROW TRANSPLANTATION
  • 2006-10. Development and Evaluation of a Generic Physiologically Based Pharmacokinetic Model for Children in CLINICAL PHARMACOKINETICS
  • 1998-09-01. Low incidence of acute graft-versus-host disease and recurrent leukaemia in patients undergoing allogeneic haemopoietic stem cell transplantation from sibling donors with methotrexate and dose-monitored cyclosporin A prophylaxis in BONE MARROW TRANSPLANTATION
  • 1994-10-01. Physiologically based pharmacokinetic study on a cyclosporin derivative, SDZ IMM 125 in JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
  • 1991-02-01. Physiologic modeling of cyclosporin kinetics in rat and man in JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
  • 1999-07-22. Developmental pharmacodynamics of cyclosporine in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s11095-010-0252-1

    DOI

    http://dx.doi.org/10.1007/s11095-010-0252-1

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1018143837

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/20811933


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Pharmacology and Pharmaceutical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Area Under Curve", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Child", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cyclosporine", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Administration Schedule", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Graft vs Host Disease", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hematopoietic Stem Cell Transplantation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Rats", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Retrospective Studies", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Tissue Distribution", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Facult\u00e9 de M\u00e9decine Lyon Sud, Universit\u00e9 Lyon 1, EA3738, CTO, F-69600, Oullins, France", 
              "id": "http://www.grid.ac/institutes/grid.7849.2", 
              "name": [
                "Universit\u00e9 de Lyon, F-69003, Lyon, France", 
                "Facult\u00e9 de M\u00e9decine Lyon Sud, Universit\u00e9 Lyon 1, EA3738, CTO, F-69600, Oullins, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "G\u00e9rard", 
            "givenName": "C\u00e9cile", 
            "id": "sg:person.0660130455.35", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660130455.35"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Facult\u00e9 de M\u00e9decine, Universit\u00e9 Lyon 1, CNRS UMR5558, F-69008, Lyon, France", 
              "id": "http://www.grid.ac/institutes/grid.7849.2", 
              "name": [
                "Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique, Lyon, France", 
                "Facult\u00e9 de M\u00e9decine, Universit\u00e9 Lyon 1, CNRS UMR5558, F-69008, Lyon, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Bleyzac", 
            "givenName": "Nathalie", 
            "id": "sg:person.01250741512.98", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01250741512.98"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Facult\u00e9 de M\u00e9decine Lyon Sud, Universit\u00e9 Lyon 1, EA3738, CTO, F-69600, Oullins, France", 
              "id": "http://www.grid.ac/institutes/grid.7849.2", 
              "name": [
                "Universit\u00e9 de Lyon, F-69003, Lyon, France", 
                "Facult\u00e9 de M\u00e9decine Lyon Sud, Universit\u00e9 Lyon 1, EA3738, CTO, F-69600, Oullins, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Girard", 
            "givenName": "Pascal", 
            "id": "sg:person.012661201622.56", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012661201622.56"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Facult\u00e9 de M\u00e9decine Lyon Sud, Universit\u00e9 Lyon 1, EA3738, CTO, F-69600, Oullins, France", 
              "id": "http://www.grid.ac/institutes/grid.7849.2", 
              "name": [
                "Universit\u00e9 de Lyon, F-69003, Lyon, France", 
                "Facult\u00e9 de M\u00e9decine Lyon Sud, Universit\u00e9 Lyon 1, EA3738, CTO, F-69600, Oullins, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Freyer", 
            "givenName": "Gilles", 
            "id": "sg:person.0636233052.33", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0636233052.33"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique, Lyon, France", 
              "id": "http://www.grid.ac/institutes/grid.452431.5", 
              "name": [
                "Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique, Lyon, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Bertrand", 
            "givenName": "Yves", 
            "id": "sg:person.01077622701.25", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077622701.25"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Pharmacie, H\u00f4pital de la Croix-Rousse, Hospices Civils de Lyon, 103 Grande rue de la Croix-Rousse, 69317, Lyon cedex 04, France", 
              "id": "http://www.grid.ac/institutes/grid.413306.3", 
              "name": [
                "Universit\u00e9 de Lyon, F-69003, Lyon, France", 
                "Facult\u00e9 de M\u00e9decine Lyon Sud, Universit\u00e9 Lyon 1, EA3738, CTO, F-69600, Oullins, France", 
                "Pharmacie, H\u00f4pital de la Croix-Rousse, Hospices Civils de Lyon, 103 Grande rue de la Croix-Rousse, 69317, Lyon cedex 04, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Tod", 
            "givenName": "Michel", 
            "id": "sg:person.0763711421.46", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0763711421.46"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.2165/00003088-200746050-00004", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1016219511", 
              "https://doi.org/10.2165/00003088-200746050-00004"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bmt.1700745", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1005934101", 
              "https://doi.org/10.1038/sj.bmt.1700745"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bmt.1704213", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038017388", 
              "https://doi.org/10.1038/sj.bmt.1704213"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bmt.1704239", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002246124", 
              "https://doi.org/10.1038/sj.bmt.1704239"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bmt.1701396", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043707730", 
              "https://doi.org/10.1038/sj.bmt.1701396"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00003088-200645090-00005", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017122603", 
              "https://doi.org/10.2165/00003088-200645090-00005"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bmt.1705481", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1050679665", 
              "https://doi.org/10.1038/sj.bmt.1705481"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1016/s0009-9236(99)70055-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001636599", 
              "https://doi.org/10.1016/s0009-9236(99)70055-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1023/a:1020978509566", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031758240", 
              "https://doi.org/10.1023/a:1020978509566"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bmt.1701954", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1039560833", 
              "https://doi.org/10.1038/sj.bmt.1701954"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf01062191", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052427388", 
              "https://doi.org/10.1007/bf01062191"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/35077251", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1023027862", 
              "https://doi.org/10.1038/35077251"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf02353860", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1015648303", 
              "https://doi.org/10.1007/bf02353860"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00003088-200645100-00005", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037331185", 
              "https://doi.org/10.2165/00003088-200645100-00005"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2010-09-02", 
        "datePublishedReg": "2010-09-02", 
        "description": "ABSTRACTPurposeCyclosporin is administered by intermittent infusions (II) or continuous infusions (CI) to prevent acute graft-versus-host disease (aGVHD). Because cyclosporin disposition is nonlinear, organ exposure may be higher after II than after CI, but saturation of receptors must be accounted for. The aim of the study was to compare both types of administration using a mechanistic model.MethodsA physiologically based pharmacokinetic model was developed to estimate cyclosporin exposure and receptor occupancies (RO) in aGVHD target organs and kidneys and to compare these estimations in pediatric patients that received cyclosporin either by II or CI. The relevant biological parameters were based on a clinical study in 2 groups of pediatric patients that received cyclosporin either by II (n\u2009=\u200931) or CI (n\u2009=\u200930).ResultsSimulations showed that the exposure to cyclosporin in the interstitial fluid of aGVHD target organs was greater at day 1 after II than after CI. In kidneys, the opposite order was observed. AUCRO in all organs was greater after CI than after II. The therapeutic index (the ratio of AUCRO in blood to AUCRO in kidneys) was greater with CI than with II.ConclusionsCI may be slightly more favorable than II for aGVHD prevention.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/s11095-010-0252-1", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1094644", 
            "issn": [
              "0724-8741", 
              "1573-904X"
            ], 
            "name": "Pharmaceutical Research", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "12", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "27"
          }
        ], 
        "keywords": [
          "continuous infusion", 
          "pediatric patients", 
          "intermittent infusion", 
          "receptor occupancy", 
          "pediatric hematopoietic stem cell transplantation", 
          "organ exposure", 
          "hematopoietic stem cell transplantation", 
          "stem cell transplantation", 
          "saturation of receptors", 
          "type of administration", 
          "acute graft", 
          "cyclosporin exposure", 
          "host disease", 
          "cell transplantation", 
          "clinical studies", 
          "target organs", 
          "therapeutic index", 
          "day 1", 
          "pharmacokinetic model", 
          "PBPK model", 
          "cyclosporin", 
          "patients", 
          "relevant biological parameters", 
          "infusion", 
          "kidney", 
          "exposure", 
          "organs", 
          "interstitial fluid", 
          "transplantation", 
          "graft", 
          "disease", 
          "administration", 
          "prevention", 
          "receptors", 
          "biological parameters", 
          "study", 
          "group", 
          "aim", 
          "opposite order", 
          "index", 
          "disposition", 
          "schedule", 
          "fluid", 
          "types", 
          "model", 
          "saturation", 
          "analysis", 
          "ResultsSimulations", 
          "influence", 
          "occupancy", 
          "parameters", 
          "order", 
          "mechanistic model", 
          "estimation"
        ], 
        "name": "Influence of Dosing Schedule on Organ Exposure to Cyclosporin in Pediatric Hematopoietic Stem Cell Transplantation: Analysis with a PBPK Model", 
        "pagination": "2602-2613", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1018143837"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s11095-010-0252-1"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "20811933"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s11095-010-0252-1", 
          "https://app.dimensions.ai/details/publication/pub.1018143837"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-12-01T06:28", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_518.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/s11095-010-0252-1"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11095-010-0252-1'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11095-010-0252-1'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11095-010-0252-1'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11095-010-0252-1'


     

    This table displays all metadata directly associated to this object as RDF triples.

    262 TRIPLES      21 PREDICATES      104 URIs      82 LITERALS      18 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s11095-010-0252-1 schema:about N134253c060184d49b602d2c1e71cae9b
    2 N37dc7ae930754ee5a551397f60214687
    3 N3a169f421a5f4cf18d1bd36c16241680
    4 N4b0f3d903311436b9cc8d6c0ceb83069
    5 N601e4d21db6249caaa51695cc25019b9
    6 N62ccd9f6308c439084ebb4ba6a1e4ee3
    7 N80e534607fd547269d7ed5a5b8a48d3b
    8 Naf5f4a77aaa94f60bf950cdc26037813
    9 Nbc53d9193d2844a9a2d048ff42ff829a
    10 Nd1c3327f21df449ea6d9b872e7f64a51
    11 Nd38095afaef246be90f06530c75217e4
    12 anzsrc-for:11
    13 anzsrc-for:1115
    14 schema:author Nef75921887804fdb9f91c140ce7b8aa6
    15 schema:citation sg:pub.10.1007/bf01062191
    16 sg:pub.10.1007/bf02353860
    17 sg:pub.10.1016/s0009-9236(99)70055-x
    18 sg:pub.10.1023/a:1020978509566
    19 sg:pub.10.1038/35077251
    20 sg:pub.10.1038/sj.bmt.1700745
    21 sg:pub.10.1038/sj.bmt.1701396
    22 sg:pub.10.1038/sj.bmt.1701954
    23 sg:pub.10.1038/sj.bmt.1704213
    24 sg:pub.10.1038/sj.bmt.1704239
    25 sg:pub.10.1038/sj.bmt.1705481
    26 sg:pub.10.2165/00003088-200645090-00005
    27 sg:pub.10.2165/00003088-200645100-00005
    28 sg:pub.10.2165/00003088-200746050-00004
    29 schema:datePublished 2010-09-02
    30 schema:datePublishedReg 2010-09-02
    31 schema:description ABSTRACTPurposeCyclosporin is administered by intermittent infusions (II) or continuous infusions (CI) to prevent acute graft-versus-host disease (aGVHD). Because cyclosporin disposition is nonlinear, organ exposure may be higher after II than after CI, but saturation of receptors must be accounted for. The aim of the study was to compare both types of administration using a mechanistic model.MethodsA physiologically based pharmacokinetic model was developed to estimate cyclosporin exposure and receptor occupancies (RO) in aGVHD target organs and kidneys and to compare these estimations in pediatric patients that received cyclosporin either by II or CI. The relevant biological parameters were based on a clinical study in 2 groups of pediatric patients that received cyclosporin either by II (n = 31) or CI (n = 30).ResultsSimulations showed that the exposure to cyclosporin in the interstitial fluid of aGVHD target organs was greater at day 1 after II than after CI. In kidneys, the opposite order was observed. AUCRO in all organs was greater after CI than after II. The therapeutic index (the ratio of AUCRO in blood to AUCRO in kidneys) was greater with CI than with II.ConclusionsCI may be slightly more favorable than II for aGVHD prevention.
    32 schema:genre article
    33 schema:isAccessibleForFree false
    34 schema:isPartOf N463a06a640444dec8b0611334537e6d7
    35 N8a9100e9bf3046bab031c94bdc1e8686
    36 sg:journal.1094644
    37 schema:keywords PBPK model
    38 ResultsSimulations
    39 acute graft
    40 administration
    41 aim
    42 analysis
    43 biological parameters
    44 cell transplantation
    45 clinical studies
    46 continuous infusion
    47 cyclosporin
    48 cyclosporin exposure
    49 day 1
    50 disease
    51 disposition
    52 estimation
    53 exposure
    54 fluid
    55 graft
    56 group
    57 hematopoietic stem cell transplantation
    58 host disease
    59 index
    60 influence
    61 infusion
    62 intermittent infusion
    63 interstitial fluid
    64 kidney
    65 mechanistic model
    66 model
    67 occupancy
    68 opposite order
    69 order
    70 organ exposure
    71 organs
    72 parameters
    73 patients
    74 pediatric hematopoietic stem cell transplantation
    75 pediatric patients
    76 pharmacokinetic model
    77 prevention
    78 receptor occupancy
    79 receptors
    80 relevant biological parameters
    81 saturation
    82 saturation of receptors
    83 schedule
    84 stem cell transplantation
    85 study
    86 target organs
    87 therapeutic index
    88 transplantation
    89 type of administration
    90 types
    91 schema:name Influence of Dosing Schedule on Organ Exposure to Cyclosporin in Pediatric Hematopoietic Stem Cell Transplantation: Analysis with a PBPK Model
    92 schema:pagination 2602-2613
    93 schema:productId N546379c931514c08a7f3590ba91a6bd9
    94 N652895bfb60548dc8f36633ab7b2d1ea
    95 Ndc786853e3a3406ebdd40dba0e6cb87b
    96 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018143837
    97 https://doi.org/10.1007/s11095-010-0252-1
    98 schema:sdDatePublished 2022-12-01T06:28
    99 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    100 schema:sdPublisher Nb45049ca224448ad80df81ea58138330
    101 schema:url https://doi.org/10.1007/s11095-010-0252-1
    102 sgo:license sg:explorer/license/
    103 sgo:sdDataset articles
    104 rdf:type schema:ScholarlyArticle
    105 N134253c060184d49b602d2c1e71cae9b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    106 schema:name Animals
    107 rdf:type schema:DefinedTerm
    108 N37dc7ae930754ee5a551397f60214687 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    109 schema:name Drug Administration Schedule
    110 rdf:type schema:DefinedTerm
    111 N3a169f421a5f4cf18d1bd36c16241680 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    112 schema:name Rats
    113 rdf:type schema:DefinedTerm
    114 N463a06a640444dec8b0611334537e6d7 schema:issueNumber 12
    115 rdf:type schema:PublicationIssue
    116 N4b0f3d903311436b9cc8d6c0ceb83069 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    117 schema:name Graft vs Host Disease
    118 rdf:type schema:DefinedTerm
    119 N4e95fa20cd6f40cb8f237f788209bc2b rdf:first sg:person.01250741512.98
    120 rdf:rest N7175fefb11484471bf9dd05524068b5b
    121 N4fe7c0b68e234436a735100e538376bc rdf:first sg:person.0763711421.46
    122 rdf:rest rdf:nil
    123 N546379c931514c08a7f3590ba91a6bd9 schema:name pubmed_id
    124 schema:value 20811933
    125 rdf:type schema:PropertyValue
    126 N601e4d21db6249caaa51695cc25019b9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    127 schema:name Tissue Distribution
    128 rdf:type schema:DefinedTerm
    129 N62ccd9f6308c439084ebb4ba6a1e4ee3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    130 schema:name Area Under Curve
    131 rdf:type schema:DefinedTerm
    132 N652895bfb60548dc8f36633ab7b2d1ea schema:name doi
    133 schema:value 10.1007/s11095-010-0252-1
    134 rdf:type schema:PropertyValue
    135 N685ec26df8e141eea9ab8a05496ff97a rdf:first sg:person.0636233052.33
    136 rdf:rest Nb7fd63e3ec5f4d06a1757dbf6440a1c5
    137 N7175fefb11484471bf9dd05524068b5b rdf:first sg:person.012661201622.56
    138 rdf:rest N685ec26df8e141eea9ab8a05496ff97a
    139 N80e534607fd547269d7ed5a5b8a48d3b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    140 schema:name Retrospective Studies
    141 rdf:type schema:DefinedTerm
    142 N8a9100e9bf3046bab031c94bdc1e8686 schema:volumeNumber 27
    143 rdf:type schema:PublicationVolume
    144 Naf5f4a77aaa94f60bf950cdc26037813 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    145 schema:name Hematopoietic Stem Cell Transplantation
    146 rdf:type schema:DefinedTerm
    147 Nb45049ca224448ad80df81ea58138330 schema:name Springer Nature - SN SciGraph project
    148 rdf:type schema:Organization
    149 Nb7fd63e3ec5f4d06a1757dbf6440a1c5 rdf:first sg:person.01077622701.25
    150 rdf:rest N4fe7c0b68e234436a735100e538376bc
    151 Nbc53d9193d2844a9a2d048ff42ff829a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    152 schema:name Humans
    153 rdf:type schema:DefinedTerm
    154 Nd1c3327f21df449ea6d9b872e7f64a51 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    155 schema:name Cyclosporine
    156 rdf:type schema:DefinedTerm
    157 Nd38095afaef246be90f06530c75217e4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    158 schema:name Child
    159 rdf:type schema:DefinedTerm
    160 Ndc786853e3a3406ebdd40dba0e6cb87b schema:name dimensions_id
    161 schema:value pub.1018143837
    162 rdf:type schema:PropertyValue
    163 Nef75921887804fdb9f91c140ce7b8aa6 rdf:first sg:person.0660130455.35
    164 rdf:rest N4e95fa20cd6f40cb8f237f788209bc2b
    165 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    166 schema:name Medical and Health Sciences
    167 rdf:type schema:DefinedTerm
    168 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
    169 schema:name Pharmacology and Pharmaceutical Sciences
    170 rdf:type schema:DefinedTerm
    171 sg:journal.1094644 schema:issn 0724-8741
    172 1573-904X
    173 schema:name Pharmaceutical Research
    174 schema:publisher Springer Nature
    175 rdf:type schema:Periodical
    176 sg:person.01077622701.25 schema:affiliation grid-institutes:grid.452431.5
    177 schema:familyName Bertrand
    178 schema:givenName Yves
    179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077622701.25
    180 rdf:type schema:Person
    181 sg:person.01250741512.98 schema:affiliation grid-institutes:grid.7849.2
    182 schema:familyName Bleyzac
    183 schema:givenName Nathalie
    184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01250741512.98
    185 rdf:type schema:Person
    186 sg:person.012661201622.56 schema:affiliation grid-institutes:grid.7849.2
    187 schema:familyName Girard
    188 schema:givenName Pascal
    189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012661201622.56
    190 rdf:type schema:Person
    191 sg:person.0636233052.33 schema:affiliation grid-institutes:grid.7849.2
    192 schema:familyName Freyer
    193 schema:givenName Gilles
    194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0636233052.33
    195 rdf:type schema:Person
    196 sg:person.0660130455.35 schema:affiliation grid-institutes:grid.7849.2
    197 schema:familyName Gérard
    198 schema:givenName Cécile
    199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660130455.35
    200 rdf:type schema:Person
    201 sg:person.0763711421.46 schema:affiliation grid-institutes:grid.413306.3
    202 schema:familyName Tod
    203 schema:givenName Michel
    204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0763711421.46
    205 rdf:type schema:Person
    206 sg:pub.10.1007/bf01062191 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052427388
    207 https://doi.org/10.1007/bf01062191
    208 rdf:type schema:CreativeWork
    209 sg:pub.10.1007/bf02353860 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015648303
    210 https://doi.org/10.1007/bf02353860
    211 rdf:type schema:CreativeWork
    212 sg:pub.10.1016/s0009-9236(99)70055-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1001636599
    213 https://doi.org/10.1016/s0009-9236(99)70055-x
    214 rdf:type schema:CreativeWork
    215 sg:pub.10.1023/a:1020978509566 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031758240
    216 https://doi.org/10.1023/a:1020978509566
    217 rdf:type schema:CreativeWork
    218 sg:pub.10.1038/35077251 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023027862
    219 https://doi.org/10.1038/35077251
    220 rdf:type schema:CreativeWork
    221 sg:pub.10.1038/sj.bmt.1700745 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005934101
    222 https://doi.org/10.1038/sj.bmt.1700745
    223 rdf:type schema:CreativeWork
    224 sg:pub.10.1038/sj.bmt.1701396 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043707730
    225 https://doi.org/10.1038/sj.bmt.1701396
    226 rdf:type schema:CreativeWork
    227 sg:pub.10.1038/sj.bmt.1701954 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039560833
    228 https://doi.org/10.1038/sj.bmt.1701954
    229 rdf:type schema:CreativeWork
    230 sg:pub.10.1038/sj.bmt.1704213 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038017388
    231 https://doi.org/10.1038/sj.bmt.1704213
    232 rdf:type schema:CreativeWork
    233 sg:pub.10.1038/sj.bmt.1704239 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002246124
    234 https://doi.org/10.1038/sj.bmt.1704239
    235 rdf:type schema:CreativeWork
    236 sg:pub.10.1038/sj.bmt.1705481 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050679665
    237 https://doi.org/10.1038/sj.bmt.1705481
    238 rdf:type schema:CreativeWork
    239 sg:pub.10.2165/00003088-200645090-00005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017122603
    240 https://doi.org/10.2165/00003088-200645090-00005
    241 rdf:type schema:CreativeWork
    242 sg:pub.10.2165/00003088-200645100-00005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037331185
    243 https://doi.org/10.2165/00003088-200645100-00005
    244 rdf:type schema:CreativeWork
    245 sg:pub.10.2165/00003088-200746050-00004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016219511
    246 https://doi.org/10.2165/00003088-200746050-00004
    247 rdf:type schema:CreativeWork
    248 grid-institutes:grid.413306.3 schema:alternateName Pharmacie, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, 103 Grande rue de la Croix-Rousse, 69317, Lyon cedex 04, France
    249 schema:name Faculté de Médecine Lyon Sud, Université Lyon 1, EA3738, CTO, F-69600, Oullins, France
    250 Pharmacie, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, 103 Grande rue de la Croix-Rousse, 69317, Lyon cedex 04, France
    251 Université de Lyon, F-69003, Lyon, France
    252 rdf:type schema:Organization
    253 grid-institutes:grid.452431.5 schema:alternateName Institut d’Hématologie et d’Oncologie Pédiatrique, Lyon, France
    254 schema:name Institut d’Hématologie et d’Oncologie Pédiatrique, Lyon, France
    255 rdf:type schema:Organization
    256 grid-institutes:grid.7849.2 schema:alternateName Faculté de Médecine Lyon Sud, Université Lyon 1, EA3738, CTO, F-69600, Oullins, France
    257 Faculté de Médecine, Université Lyon 1, CNRS UMR5558, F-69008, Lyon, France
    258 schema:name Faculté de Médecine Lyon Sud, Université Lyon 1, EA3738, CTO, F-69600, Oullins, France
    259 Faculté de Médecine, Université Lyon 1, CNRS UMR5558, F-69008, Lyon, France
    260 Institut d’Hématologie et d’Oncologie Pédiatrique, Lyon, France
    261 Université de Lyon, F-69003, Lyon, France
    262 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...